IGEPHARMA
Business purpose.
Fabrication de produits pharmaceutiques, diététiques, cosmétiques et vétérinaires ; conception, commercialisation et courtage de produits pharmaceutiques, diététiques, cosmétiques et vétérinaires
IGEPHARMA is a company registered under SIREN number 404085060, with its registered office in SAINT-BEAUZIRE. Its main activity falls under the sector: Manufacture of basic pharmaceutical products and pharmaceutical preparations. 1 serving director is recorded in the national business register. Its reported revenue for the financial year ended in 2026 is 0 euros.
Sources: INSEE Sirene, INPI RNE, INPI, annual accounts.
Identity
- Legal form
- SARL (no further detail)
- Activity
- Manufacture of pharmaceutical preparations (21.20Z)
- Sector
- Manufacture of basic pharmaceutical products and pharmaceutical preparations
- Headcount
- 20 to 49 employees
- Created
- 20 Feb 1996
- Share capital
- 46,000.00 EUR
- Registered with the trade register
- 27 Feb 1996
- Financial year end
- 31/01
- Establishments
- 1
Directors
- DOMINIQUE PAULET 64 years old, 08/1962 Gerant
Related companies
Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.
- DOMINIQUE PAULET via DOMINIQUE PAULET
Other companies at the same address
36 other company head offices are registered at this address.
Establishments
Financial strength
Financial score
75 / 100 B
Confidence: medium · computed on the financial year ended 31 Jan 2026
- Equity to assets (65.4 %)
- 23.0 out of 30
- EBITDA margin
- data missing, component not taken into account
- Liquidity (294.9 %)
- 11.8 out of 20
- Debt (5.3 %)
- 14.1 out of 15
- Revenue trend
- data missing, component not taken into account
formula fin-1.0
Legal score
100 / 100 A
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (30.7 years)
- 20.0 out of 20
- Accounts filed recently
- 20.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Revenue and earnings
Detailed accounts for this company are not reproduced here, but its main aggregates are public.
Revenue Net income
| Financial year | Revenue | Change | EBITDA | Net income |
|---|---|---|---|---|
| 31 Jan 2026 | 0 € | — | 0 € | 189,506 € |
| 31 Jan 2025 | 0 € | — | 0 € | 162,625 € |
| 31 Jan 2024 | 0 € | — | 0 € | 283,234 € |
| 31 Jan 2023 | 0 € | — | 0 € | 151,812 € |
| 31 Jan 2022 | 0 € | first year on record | 0 € | 144,640 € |
Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.
Explore similar companies
Collective agreements
Agreements declared by the employer in its payroll filings.
-
Convention collective nationale de la fabrication et du commerce des produits à usage pharmaceutique, parapharmaceutique et vétérinaire du 1er juin 1989. Etendue par arrêté du 20 avril 1990 JORF 29 avril 1990
IDCC 1555 · repealed · 1 establishment · declared in August 2026
Legal notices
-
Filing of accounts 31 Aug 2026
- Court :
- Greffe du Tribunal de Commerce de clermont-ferrand
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/01/2026
BODACC C n 20260166, annonce n 2640 · Proof of publication (PDF)
-
Filing of accounts 5 Aug 2025
- Court :
- Greffe du Tribunal de Commerce de clermont-ferrand
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/01/2023
BODACC C n 20250148, annonce n 6369 · Proof of publication (PDF)
-
Filing of accounts 5 Aug 2025
- Court :
- Greffe du Tribunal de Commerce de clermont-ferrand
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/01/2024
BODACC C n 20250148, annonce n 6370 · Proof of publication (PDF)
-
Filing of accounts 5 Aug 2025
- Court :
- Greffe du Tribunal de Commerce de clermont-ferrand
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/01/2025
BODACC C n 20250148, annonce n 6371 · Proof of publication (PDF)
-
Filing of accounts 5 Aug 2025
- Court :
- Greffe du Tribunal de Commerce de clermont-ferrand
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/01/2022
BODACC C n 20250148, annonce n 6368 · Proof of publication (PDF)
-
Amendment 29 Jul 2025
- Court :
- Greffe du Tribunal de Commerce de Clermont-Ferrand
- Amendment :
- Modification survenue sur l'administration.
BODACC B n 20250143, annonce n 3667 · Proof of publication (PDF)
Filings and accounts
- Formality 28 Jul 2025
- Formality 23 Jul 2025
- Formality 18 Jul 2025
Change history
- officer_appointed (empty) → Gerant 9 Oct 2026
- registered_address (empty) → Biopôle Clermont Limagne Rond Point du Biopôle 63360 Saint-Beauzire 2 Oct 2026
Frequently asked questions about IGEPHARMA
- What is the SIREN number of IGEPHARMA?
- The SIREN number of IGEPHARMA is 404085060. Its intra-community VAT number is FR20404085060.
- Where is the head office of IGEPHARMA?
- Head office address: BIOPOLE CLERMONT LIMAGNE, 63360 SAINT-BEAUZIRE.
- When was IGEPHARMA founded?
- IGEPHARMA was founded on 20 Feb 1996.
- What does IGEPHARMA do?
- Its declared main activity is: Manufacture of pharmaceutical preparations (NAF code 21.20Z).
- Who runs IGEPHARMA?
- The officer listed in the register is DOMINIQUE PAULET (Gerant).
- What is the revenue of IGEPHARMA?
- The latest published revenue is 0 €, for the 2026 financial year.
- How many employees does IGEPHARMA have?
- The declared headcount is 20 to 49 employees. Insee data for 2024.
- Is IGEPHARMA subject to insolvency proceedings?
- No ongoing insolvency proceedings are published in the BODACC for this company.